NCT01611142 2024-06-17
Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)
Kyowa Kirin Co., Ltd.
Phase 2 Completed
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
National Institutes of Health Clinical Center (CC)
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.